Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio” or the “Company”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit ...

Accelerating Gene Design, Strain Optimization, and Bioprocess Control for Next-Generation Biomanufacturing We are committed to advancing synthetic biology through the power of AI... BioSynthAI™’s ...

AI might already be hiding its real capabilities. That’s what Dr. Roman Yampolskiy told Rogan in a podcast episode that will ...

Top 5 Synthetic Biology Companies Selection This top 5 has been created to highlight companies following the criteria below. (This is not investment advice. Order is by valuation and might not reflect ...

The Korvaa Consortium tapped Modern Synthesis, Ecovative and Ourobio to develop the debut shoe made with mycelium, bacterial ...

Today, these microbial partners work in the soil across millions of acres of farmland worldwide, helping farmers grow more ...

Synthetic biology holds much promise for the life sciences sector as it continues to look for new ways of treating disease and accelerating drug development, says Debiopharm's Tanja Dowe ...

Explore how AI enables the design of synthetic proteins with DenovAI's groundbreaking study in Molecular Systems Biology.

The partners will use UNP's AI-based macrocycle discovery platform to develop synthetic peptide therapeutics for multiple disease targets.

A startup called Gigablue claims to have reached a milestone by selling 200,000 carbon credits for its ocean-based carbon ...